1)Takahashi S, Takeyama K, Kunishima Y, et al:Analysis of clinical manifestations of male patients with urethritis. J Infect Chemother 12:283-286, 2006
2)Takahashi S, Matsukawa M, Kurimura Y, et al:Clinical efficacy of azithromycin for male nongonococcal urethritis. J Infect Chemother 14:409-412, 2008
3)Takahashi S, Ichihara K, Hashimoto J, et al:Clinical efficacy of levofloxacin 500mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 17:392-396, 2011
4)Takahashi S, Hamasuna R, Yasuda M, et al:Clinical efficacy of sitafloxacin 100mg twice daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 19:941-945, 2013
5)Takahashi S, Kiyota H, Ito S, et al:Clinical efficacy of a single two gram dose of azithromycin extended release for male patients with urethritis. Antibiotics 3:109-120, 2014
6)Manhart LE, Gillespie CW, Lowens MS, et al:Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates:a randomized controlled trial. Clin Infect Dis 56:934-942, 2013
2014. MMWR 63:1-19, 2014
infection in a subgroup of young men in the UK. Lancet 361:1792, 2003
9)Takahashi S, Takeyama K, Miyamoto S, et al:Incidence of sexually transmitted infections in asymptomatic healthy young Japanese men. J Infect Chemother 11:270-273, 2005
, Japan. Emerg Infect Dis 17:148-149, 2011
strain isolated in Argentina. Sex Transm Dis 36:787-788, 2009
from male urethritis in Japan. J Infect Chemother 19:571-578, 2013
initiating a future era of untreatable gonorrhea?:detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538-3545, 2011
-positive nongonococcal urethritis in men. Clin Infect Dis 41:1357-1359, 2005
in nongonococcal urethritis:the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 58:631-637, 2014
16)Ito S, Yasuda M, Seike K, et al:Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J Infect Chemother 18:414-418, 2012
infection in sexual partnerships. JAMA 276:1737-1742, 1996
18)Takahashi S, Kurimura Y, Hashimoto J, et al:Management for males whose female partners are diagnosed with genital chlamydial infection. J Infect Chemother 17:76-79, 2011